Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawn

Clopidogrel Teva Pharma(clopidogrel)

Ischemic Attack, Transient;Peripheral Vascular Diseases;Myocardial Infarction;Acute Coronary Syndrome

Marketing Authorisation Holder: Teva Pharma B.V.

INN: clopidogrel

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Clopidogrel Teva Pharma — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Clopidogrel Teva PharmaCreate Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.